COURTNEY NGO: Open Payments
NPI 1568073070 · STERLING, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,879 in 142 payments from 17 companies in 2025. Trend: 2023 $1,185 · 2024 $746 · 2025 $2,879
Food & beverage: $2,800Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $552 |
| Janssen Biotech, Inc. | 11 | $340 |
| Gilead Sciences, Inc. | 11 | $270 |
| Ardelyx, Inc. | 14 | $229 |
| Phathom Pharmaceuticals, Inc. | 19 | $223 |
| PFIZER INC. | 10 | $202 |
| QOL Medical, LLC | 7 | $155 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $147 |
| GENZYME CORPORATION | 5 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $146 |
Products named: TREMFYA, RINVOQ, IBSRELA, VOQUEZNA, Sucraid, XIFAXAN, DUPIXENT, XELJANZ.
Industry payments across VA — which companies pay providers there.
